Management of Secondary Hyperparathyroidism

Initial Assessment

The National Kidney Foundation recommends that a vitamin D level of 39 ng/mL is sufficient and does not require supplementation, as levels above 30 ng/mL are considered adequate 1, 5
Evaluation for modifiable factors that could cause secondary hyperparathyroidism is the first step in patients with normal calcium and elevated PTH, according to the Kidney International guidelines 3, 4
Checking for hyperphosphatemia is crucial, as it can contribute to elevated PTH even with normal calcium, as stated by the American Journal of Kidney Diseases 4, 5
Assessing renal function (BUN, creatinine) is necessary to rule out chronic kidney disease as a cause of secondary hyperparathyroidism, as recommended by the American Journal of Kidney Diseases 5

Measuring serum phosphorus level can help determine the underlying cause of elevated PTH with normal calcium, according to the Kidney International guidelines 3
Confirming normal calcium with ionized calcium measurement is essential, as total calcium may be misleading, as stated by the American Journal of Kidney Diseases 5
Checking 24-hour urine calcium and phosphorus can assess for hypercalciuria or renal phosphate wasting, as recommended by the Kidney International guidelines 6
Measuring bone-specific alkaline phosphatase can assess for metabolic bone disease, according to the American Journal of Kidney Diseases 5
Checking magnesium levels is necessary, as hypomagnesemia can cause functional hypoparathyroidism, as stated by the American Journal of Kidney Diseases 5

The American Journal of Kidney Diseases recommends that no vitamin D supplementation is needed if the vitamin D level is already sufficient (>30 ng/mL) 1, 5
If phosphate levels are elevated, considering dietary phosphate restriction and potentially phosphate binders is necessary, as recommended by the Kidney International guidelines 3, 4
If hypercalciuria is detected on 24-hour urine collection, limiting dietary calcium intake is essential, according to the Gut guidelines 6
For patients with normal renal function and no identifiable cause, referral to endocrinology is appropriate to evaluate for primary hyperparathyroidism, as stated by the American Journal of Kidney Diseases 5

In patients with chronic kidney disease, the optimal PTH level is not known, but persistently elevated levels warrant evaluation for modifiable factors, according to the Kidney International guidelines 4, 7
Avoiding routine use of calcitriol or vitamin D analogs in patients with normal calcium and elevated PTH unless there is severe and progressive hyperparathyroidism is recommended by the Kidney International guidelines 4, 8

Rechecking calcium, phosphorus, and PTH in 3 months to assess for changes is necessary, as recommended by the Kidney International guidelines 4, 5
If PTH continues to rise despite addressing modifiable factors, endocrinology consultation is warranted, according to the Kidney International guidelines 4, 5
Considering bone density testing if elevated PTH persists is essential, as chronic hyperparathyroidism can lead to bone loss, as stated by the Gut guidelines 6